N/A N=8 Randomized Double-blind Other

Whole Body Protein Metabolism of a Whey/EAA Supplement Using Continuous Oral Stable Isotopes

Healthy

Bottom Line

View on ClinicalTrials.gov: NCT04612400 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2023

Primary outcome: Primary: Whole-body Protein Net Balance — 6.2; 11.8 grams

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Oral amino acid tracer (Other)
Age: Adult · 21+ yrs
Sex: All
Sponsor: University of Arkansas
Primary completion: Sep 2021

Outcome Measures

Outcome	Result	p-value
PRIMARY Whole-body Protein Net Balance	6.2; 11.8	—

Summary

To evaluate the validity of a continuous oral sip-feeding method of stable isotope tracer for the evaluation of whole-body protein metabolism in response to two different doses of an EAA/whey protein supplement (Low=6.3g and High=12.6g). Results will be compared to those previously determined by constant infusion with the same EAA/whey supplement.

Eligibility Criteria

Inclusion Criteria

Aged 21-40 years.
Body weight of ≤ 80kg.

Exclusion Criteria

History Chronic kidney disease.
History of dairy allergy or intolerance.
History of gastric reduction/bypass surgery.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04612400). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.